Using SGLT2i safely in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests if a special monitoring system can help people with type 1 diabetes use SGLT2i medications safely, alongside insulin and a continuous glucose monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be over 18 years old
- Diagnosed with type 1 diabetes for at least one year
- Using a stable insulin plan (pump or injections) for at least 8 weeks
- Currently using a continuous glucose monitor (CGM)
- Kidney function (eGFR) must be 60 or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a dual continuous ketone and glucose monitor to help prevent diabetic ketoacidosis (DKA) in people with type 1 diabetes who are starting SGLT2 inhibitor treatment. SGLT2 inhibitors are a newer type of diabetes medicine, but they can increase the risk of DKA. The device may make using these medicines safer.
This study tests a new sensor that continuously measures ketone levels in people with type 1 diabetes who are also taking SGLT2 inhibitors. It aims to see if the sensor can help prevent diabetic ketoacidosis.
This study tests a device that monitors ketone levels to help reduce the risk of diabetic ketoacidosis (DKA) for people with type 1 diabetes who are taking a class of medications called SGLT-2 inhibitors. The goal is to see if regular ketone tracking can make these medications safer.
This study tests whether a diabetes medication called dapagliflozin works better when paired with continuous glucose monitoring (a sensor that checks blood sugar all day) compared to finger-stick blood tests. The goal is to help you control your blood sugar more effectively.
This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.
This study tests whether a medication called dapagliflozin (a type of SGLT2 inhibitor) can be used safely in people with type 1 diabetes by checking blood ketone levels. It may help find a way to lower the risk of a serious condition called ketoacidosis while using this medication.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.